Acupuncture Therapy for COVID-Related Olfactory Loss
NCT04952389
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Olfactory Dysfunction
COVID-19
Interventions
DEVICE:
Acupuncture Therapy
DRUG:
Budesonide
OTHER:
Olfactory Training
Sponsor
Mayo Clinic